AzTrials
AzTrials

Bipolar Affective DisorderNCT03249857

Study of Sensorimotor Compatibility Effects in Bipolar Affective Disorder.

A study testing cognitive tasks + IQ + MINI and cognitive tasks in people with Bipolar Affective Disorder, run by Centre Hospitalier Universitaire de Saint Etienne at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Based in an embodied approach of cognition, several studies have highlighted a direct link between perception of an object or an emotion and the associated motor responses. This study investigated in patients suffering from bipolar affective disorders whether the perception of emotional words involves an automatic… Read more about this study

Who is it for?
Ages 18 to 55 yearsHealthy volunteers can take part
Conditions the study is for
Bipolar Affective Disorder
What is being tested?
cognitive tasks + IQ + MINI and cognitive tasks
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteFrance
Study dates
26 Oct 2017to 21 Aug 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 55 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • For patients:
  • Affiliated or entitled to a social security
  • Aged between 18 and 55
  • Patients of both sexes suffering from bipolar disorders (DSM V criteria) whatever the subtype
  • Stabilized from a point of view clinical and therapeutic
  • Euthymic (score <7 at the Hamilton scale, and score <8 at Young's scale)
Show all 13Show fewer
  • Must have given their informed consent before their participation in the study
  • Be right-handed (score> 14 on the laterality scale)
  • For control group:
  • Affiliated or entitled to a social security
  • Must have given their informed consent before their participation in the study
  • Be right-handed (score> 14 on the lateral scale)
  • Aged 18 to 55 matched by age (± 5 years), sex, and on the study level of patients (years of schooling after primary school ± 2 years)

Who cannot join

  • For patients:
  • Thymic acute decompensation
  • Hamilton scale > 8, Young's scale > 9
  • Montreal Cognitive Assessment (MOCA) <26
  • History neurological pathology with cerebral impairment or serious somatic disease
  • Disorders related to the use of a psychoactive substance, as defined by the DSM-V (abuse, dependence or withdrawal) within 6 months.
Show all 14Show fewer
  • IQ < 70
  • History of head trauma
  • For control group:
  • History of head trauma
  • Neurological pathology with cerebral impairment or serious somatic disease
  • Psychotropic treatment
  • Disorders related to the use of a psychoactive substance, as defined by the DSM-V (abuse, dependence or withdrawal)
  • IQ < 70

Trial locations and contacts

1 site in 1 country.

France1 site
  • Chu Saint-Etienne

    Saint-Etienne, 42055

Other trials in France

About this study

Based in an embodied approach of cognition, several studies have highlighted a direct link between perception of an object or an emotion and the associated motor responses. This study investigated in patients suffering from bipolar affective disorders whether the perception of emotional words involves an automatic sensorimotor simulation of approach and avoidance behaviors, and whether the perception of an object involves an automatic sensorimotor simulation of object prehension (affordance). We hypothesize that, in this pathology, low level (sensorimotor) cognitive processes are preserved whereas high-level (attentional) are altered. 20 patients suffering from bipolar affective disorders and 20 healthy controls will be recruited. The main objective is the emergence of sensorimotor compatibility effects in approach-avoidance task with emotional stimuli (gain between compatible vs incompatible conditions).

Being tested
cognitive tasks + IQ + MINI, cognitive tasks
Keywords
Bipolar affective disorders, Cognition, Emotion, Embodiment, Sensorimotor, Simulation
Medical subject headings
Bipolar Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • cognitive tasks + IQ + MINIBehavioural

    Patients will perform different tasks:

    • cognitive tasks : reaction time (Alert TEA, Zimmermann and Fimm, 2005) + Edinburgh laterality questionnaire (Oldfield,1971) + hamilton and young's scale (Tohen et al., 2009) + Montreal Cognitive Assessment (MoCA) (Nasreddine et al., 2005) + experimental task (approach/ avoidance and affordance task).
    • Intelligence Quotient (IQ) test (PM38, Raven, 1960)
    • Mini International Neuropsychiatric Interview (MINI, Van Vliet et al., 2006)
  • cognitive tasksBehavioural

    Healthy volunteers will perform only the cognitive tasks = reaction time alert TEA, Zimmermann and Fimm, 2005 + Edinburgh laterality questionnaire (Oldfield, 1971) + experimental task (approach/ avoidance and affordance task).

Study groups in NCT03249857
Study groupRoleWhat they receive
patientsExperimentalPatients suffering bipolar affective disorders and who will perform cognitive tasks + IQ + MINI + experimental task
Receives: Behavioral: cognitive tasks + IQ + MINI
control groupActive comparatorHealthy volunteers (Control group) who will perform cognitive tasks + experimental task
Receives: Behavioral: cognitive tasks

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. response time for avoidance and affordance task

    Comparison of response time for avoidance and affordance task between patients and healthy volunteers.

    Measured: Months 24

Secondary outcomes (3)
  1. response time for affordance task

    Comparison of response time for affordance task between patients and healthy volunteers.

    Measured: Months 24

  2. correlations with age at onset of the disease, the number of thymic decompensations and the existence of psychotic symptoms

    These informations were collected of the medical file.

    Measured: Months 24

  3. response time and cognitive tests

    Correlation between response time and cognitive tests of patients and healthy volunteers.

    Measured: Months 24

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Aug 2017
  2. Study start26 Oct 2017
  3. Primary completion21 Aug 2018
  4. Study completion21 Aug 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03249857
Sponsor's protocol ID
1708056
Other IDs
2017-A00917-46
Status last verified
Jan 2020
First submitted
10 Aug 2017
Last updated
9 Jan 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing cognitive tasks + IQ + MINI and cognitive tasks in people with Bipolar Affective Disorder, run by Centre Hospitalier Universitaire de Saint Etienne at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 13 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

response time for avoidance and affordance task (time frame: Months 24). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jan 2020; AzTrials last refreshed its copy on 31 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in